Axolotl Biologix Inc is a biotechnology company based in Flagstaff, AZ that specializes in the development and distribution of graft products. Their innovative Axolotl Graft and Axolotl DualGraft are designed to be efficient, effective, and safe for clinical use, utilizing a proprietary BioSym process that includes rigorous screening and testing procedures. Marketed under regulatory oversight, their products are biocompatible and have a low risk of immunogenicity, making them highly suitable for transplantation.
With a focus on natural ingredients found in the body, Axolotl Biologix ensures that their graft products are of the highest quality. Their ongoing research and investigation of the Axolotl Ambient as an Investigational New Drug product by the FDA further demonstrates their commitment to scientific advancement in the field. Offering a range of sizes, their graft products can be used as wound coverings and structural barriers, providing effective solutions for various medical applications.
Generated from the website